Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Robert Gould

ID: 1b833d91-2619-30fb-68c4

/

Claimed Record

/

Organization: Husch Blackwell LLP

Patent issues will remain after FDA approval of Sandoz’ application for filgrastim

Healthcare Law Insights · January 9, 2015

Practice Areas

Health Care and Life Sciences

Jurisdictions

Publishing Record

Publisher Since 2015

Total Articles 1

Most Recent January 9, 2015

Cite This Author

Robert Gould, Husch Blackwell LLP

LexBlog Author ID:

1b833d91-2619-30fb-68c4

www.lexblog.com/author/rgould

Contact

FirmHusch Blackwell LLP

Emailrobert.gould@huschblackwell.com

BlogHealthcare Law Insights

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog